GLSI NASDAQ
Greenwich LifeSciences, Inc.
1W: +7.3%
1M: -6.3%
3M: +36.1%
YTD: -10.5%
1Y: +74.4%
3Y: +110.4%
5Y: -53.2%
$17.42
+0.29 (+1.72%)
Weekly Expected Move ±11.8%
$12
$14
$16
$18
$20
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -49.07.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$255.7M
52W Range7.78-34.1
Volume223,599
Avg Volume142,744
Beta1.46
Dividend—
Analyst Ratings
Company Info
CEOSnehal S. Patel
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2020-09-25
Websitegreenwichlifesciences.com
Building 14
Stafford, TX 77477
US
Stafford, TX 77477
US
832 819 3232
About Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.
Latest News
Greenwich LifeSciences (NASDAQ:GLSI) Stock Falls 2.1% – Time to Sell?
$GLSI shows Less Than 1k Shares Available to Short
$GLSI shows Less Than 1k Shares Available to Short
What is HC Wainwright’s Forecast for GLSI FY2026 Earnings?
Greenwich LifeSciences receives Nasdaq notice regarding late Form 10-K filing
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Patel Snehal | P-Purchase | 700 | $13.10 | 2026-07-29 |
| Patel Snehal | P-Purchase | 1,500 | $13.59 | 2026-07-28 |
| Patel Snehal | P-Purchase | 1,500 | $13.62 | 2026-07-27 |
| Patel Snehal | P-Purchase | 1,100 | $12.88 | 2026-07-24 |
| Patel Snehal | P-Purchase | 2,500 | $13.14 | 2026-07-23 |